ESG Report 2023

7.1.2 Quality Certification and Awards The obtainment of a credible quality certification can ensure the pharmaceuticals contribute to customers' health and increase customers' confidence in the products. The Group is a leading comprehensive pharmaceutical enterprise in China that has obtained the integrative GMP certification. We always strictly comply with the relevant requirements to continuously meet the related standards in the certification. Besides, the Group's multiple products of active pharmaceutical ingredients have obtained certifications from official authoritative institutions, such as China Quality Certification Centre, CNAS, Certificate of Suitability to the Monographs of the European Pharmacopoeia, FDA, Germany BVG Hamburg and Mexico COFEPRIS. We attach great importance to quality-certification-related work and also passed several quality certifications during the Year: The Quality Inspection Centre has been accredited by CNAS, the National Laboratory accreditation authority, for 13 consecutive years. The Group’s Quality Certifications in the Year Zhuhai Company Non-sterile active pharmaceutical ingredients (APIs) such as amoxicillin and ampicillin have passed GMP certification inspections from European Union countries. Tartrate vancomycin veterinary medicine has obtained production licenses and passed GMP inspections. Inner Mongolia Company The oral solution production line has achieved GMP certification. The United Animal Healthcare 38 " Be a Quality Enterprise, Prosperous and Strong " is the Group's production philosophy. We guarantee the quality of our medicines, contributes to the development of Chinese pharmaceuticals, and have won widespread praise in the industry and society. Zhuhai Company has been honored with a total of 12 outstanding brand certificates, including the Excellent Enterprise Brand of Bulk Medicine Export and Excellent Enterprise Brand of Pharmaceutical Products Export by China Pharmaceutical Industry Association. In addition, the Group is also deeply engaged in the lower-tier markets to protect the health of consumers with high-quality products and services. The ® Group's 阿莫仙 (Amoxicillin) was awarded the Gold Brand Award in the Antibiotics category of the “2023 Health Industry Brand Rankings”. ® 阿莫仙 is the first semi-synthetic penicillin oral product to be manufactured and sold in China by the Group, and is recommended by the World Health Organisation's List of Essential Medicines. It is also one of the most widely used semi-synthetic penicillin antibiotics in the world. Environmental, Social and Governance Report 2023 The United Laboratories International Holdings Limited In addition, we have set up procedures for the release of products. The procedures stipulated that only raw materials, semi-finished and finished products that have passed quality tests could be passed to the next procedure to avoid the use of any raw materials, semi-finished and finished products that are non-conforming to standards and specifications for production or sale. For non-conforming raw materials and finished products, we will identify, investigate, return or collectively destroy them based on the relevant management procedures for non-conforming products. In order to further improve quality management, the Group would conduct annual review of product quality every year, and carry out evaluation and propose improvement methods for all the quality indicators, deviations in production process and changes of production equipment. This helps to continually refine the Group's quality management system. Inner Mongolia Company also successfully passed the certification audit of quality, environment and occupational health and safety management system during the Year to ensure the comprehensive and effective operation of the management system.